← Back to Search

Smartphone App for Smoking Cessation

N/A
Recruiting
Led By Christine Vinci, PhD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age
Daily smokers that have quit smoking within the past 3 months (Aim 1) or currently smoking ≥ 3 cigarettes per day for the past year (Aim 2)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1 week
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if using a smartphone app can help smokers quit by using cues to help them resist cravings.

Who is the study for?
This trial is for adults over 18 who smoke daily and either quit within the last 3 months or currently smoke at least 3 cigarettes a day. Participants must have a smartphone that supports AR, be willing to download an app, and speak English. People with another household member in the study can't join.
What is being tested?
The study tests if using a smartphone app that exposes users to smoking cues can help people stop smoking when combined with Quitline services. Some will use just Quitline services, others will get additional support from updating an existing app.
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience increased cravings or stress during cue exposure through the app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I quit smoking recently or smoke at least 3 cigarettes daily for the past year.
Select...
I own a smartphone that supports AR and am willing to download an app.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
System Usability Scale (Aim 1)
Tobacco Abstinence (Aim 2)
Secondary study objectives
User Satisfaction (Aim 1)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Aim 2:Quitline plus smartphone AppExperimental Treatment3 Interventions
Participants randomized to this arm will receive usual care for smoking cessation via the quitline and a smartphone app that will allow them to track smoking urges and abstinence. After 48 hours of self-reported abstinence, they will be exposed to smoking extinction trials through the study smartphone app.
Group II: Aim 2: Quit Line OnlyExperimental Treatment1 Intervention
Participants randomized to this arm will receive usual care for smoking cessation via the quitline and a smartphone app that will allow them to track smoking urges and abstinence.
Group III: Aim 1: Update an existing smartphone AppExperimental Treatment1 Intervention
An existing study app will be updated to be engaging, user-friendly treatment tool, and verify user satisfaction.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,327,733 Total Patients Enrolled
68 Trials studying Smoking
20,684 Patients Enrolled for Smoking
H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
567 Previous Clinical Trials
142,837 Total Patients Enrolled
3 Trials studying Smoking
271 Patients Enrolled for Smoking
Christine Vinci, PhDPrincipal InvestigatorMoffitt Cancer Center
3 Previous Clinical Trials
619 Total Patients Enrolled
~961 spots leftby Dec 2025